Biological characterization of subgroups of squamous cell lung carcinomas

Clinical Cancer Research

Volumn 5, Issue 6, 1999, Pages 1459-1463

  Mattern, Jürgen ^a   Koomägi, Reet ^a   Volm, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLINE; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CELL PROLIFERATION; CELL SURVIVAL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ADULT; AGED; ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOKINES; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PLATELET-DERIVED GROWTH FACTOR; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0345280025     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285: 1182-1186, 1971.
2. Folkman, J. Tumor angiogenesis. In: J. F. Holland, R. C. Bast, D. L. Morton, E. Frei, D. W. Kufe, and R. R. Weichselbaum (eds.), Cancer Medicine, pp. 181-204. Baltimore: Williams & Wilkins, 1997.
3. Gasparini, G. Prognostic and predictive value of intra-tumoral microvessel density in human solid tumours. In: R. Bicknell, C. E. Lewis, and N. Ferrara (eds.), Tumour Angiogenesis, pp. 29-44. Oxford: Oxford University Press, 1997.
4. Leedy, D. A., Trune, D. R., Kronz, J. D., Weidner, N., and Cohen, J. I. Tumor angiogenesis, the p53 antigen and cervical metastasis in squamous carcinoma. Otolaryngol. Head Neck Surg., 111: 417-422, 1994.
5. Axelsson, K., Ljung, B-M. E., Moore, D. H., Thor, A. D., Chew, K. L., Edgerton, S. M., Smith, H. S., and Mayall, B. H. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J. Natl. Cancer Inst. (Bethesda), 87: 997-1008, 1995.
6. Chandrachud, L. M., Pendleton, N., Chrisholm, D. M., Horan, M. A., and Schor, A. M. Relationship between vascularity, age and survival in non-small cell lung cancer. Br. J. Cancer, 76: 1367-1375, 1997.
7. Pezzella, F., Pastorino, U., Tagliabue, E., Andreola, S., Sozzi, G., Gasparini, G., Menard, S., Gatter, K. C., Harris, A. L., Fox, S., Buyse, M., Pilotti, S., Pierotti, M., and Rilke, F. Non-small cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am. J. Pathol., 151: 1417-1423, 1997.
8. WHO. Histological typing of lung tumors. Tumori, 6: 253-272, 1981.
9. Carr, D. T., and Mountain, C. F. Staging lung cancer. In: M. J. Strauss (ed.), Lung Cancer, Clinical Diagnosis and Treatment, pp. 151-161. New York: Grune & Stratton, 1977.
10. Volm, M., Bak, M., Efferth, T., Lathan, B., and Mattern, J. Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res., 8: 531-536, 1988.
11. Volm, M., Mattern, J., and Samsel, B. Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein, and glutathione S-transferase-π in human lung tumors. Cancer (Phila.), 71: 3181-3187, 1993.
12. Mattern, J., Jäger, S., Sonka, J., Wayss, K., and Volm, M. Growth of human bronchial carcinomas in nude mice. Br. J. Cancer, 51: 195-200, 1985.
13. Mattern, J., Bak, M., Hahn, E. W., and Volm, M. Human tumor xenografts as model for drug testing. Cancer Metastasis Rev., 7: 263-284, 1988.
14. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
15. Christofori, G., Naik, P., and Hanahan, D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol. Endocrinol., 9: 1760-1770, 1995.
16. Christofori, G. The role of fibroblast growth factors in tumour progression and angiogenesis. In: R. Bicknell, C. E. Lewis, and N. Ferrara (eds.), Tumour Angiogenesis, pp. 201-237. Oxford: Oxford University Press, 1997.
17. Mattern, J., Koomägi, R., and Volm, M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer, 73: 931-934, 1996.
18. Mattern, J., Stammler, G., Koomägi, R., Wallwiener, D., Kaufmann, M., and Volm, M. Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. Anticancer Res., 17: 621-624, 1997.
19. Pastorino, U., Andreola, S., Tagliabue, E., Pezzella, F., Incarbone, M., Sozzi, G., Buyse, M., Menard, S., Pierotti, M., and Rilke, F. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J. Clin. Oncol. 15: 2858-2865, 1997